-The Times of India NEW DELHI: Over 200 cancer drugs, 186 medicines to treat cardiovascular diseases and 148 stents and cardiac implants will now be available at central government hospitals at prices 50-60% lower than the open market. The health ministry has launched a programme called AMRIT (Affordable Medicines and Reliable Implants for Treatment), under which the government will run pharmacy retail stores to sell medicines in hospitals like All India Institute...

-The Economic Times Blog Two apparently unrelated events — a sharp fall in factory output growth and a spike in consumer price inflation —point to deep problems underlying the economy. September industry growth fell to 3.6%, the lowest in four months. Meanwhile, the consumer price index (CPI) went up to 5% in October, higher than the consensus estimate of 4.8%, headed north for the third successive month. The rise in prices is driven...

-The Indian Express Government cannot afford to wait any longer to address the building agricultural distress. The government and the political class seem oblivious to a deepening farm crisis, resulting from back-to-back monsoon failures and falling crop prices. One indicator of the growing agrarian distress is farmer suicides, no longer a phenomenon confined to Vidarbha or Telangana. The current year has seen farmers even in states like Karnataka, Odisha and Madhya...

-Asian Age Many years ago, when I was doing my Ph.D. in genetics at the Indian Agricultural Research Institute, Delhi, I did my research on mung and urad daal, unlike most of my compatriots who did their research either on the major cereals like wheat, rice and maize, or on vegetables. Pulses was a neglected field of research then, as it is now. It was a crop of the marginal areas...

-The Times of India NEW DELHI: New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight. The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs...